ARTSCAN III: a randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck …
M Gebre-Medhin, E Brun, P Engström… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE We performed an open-label randomized controlled phase III study comparing
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …
ARTSCAN III: A randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck …
M Gebre-Medhin, E Brun, P Engström… - Journal of Clinical …, 2021 - lup.lub.lu.se
PURPOSE We performed an open-label randomized controlled phase III study comparing
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …
ARTSCAN III: A randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck …
M Gebre-Medhin, E Brun, P Engström… - Journal of Clinical …, 2021 - portal.research.lu.se
PURPOSE We performed an open-label randomized controlled phase III study comparing
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …
ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and …
M Gebre-Medhin, E Brun… - Journal of clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose We performed an open-label randomized controlled phase III study comparing
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …
ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and …
M Gebre-Medhin, E Brun, P Engström… - Journal of Clinical …, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> PURPOSE</jats: title>< jats: p> We performed an open-label
randomized controlled phase III study comparing treatment outcome and toxicity between …
randomized controlled phase III study comparing treatment outcome and toxicity between …
ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and …
M Gebre-Medhin, E Brun, P Engström… - Journal of Clinical …, 2020 - europepmc.org
Purpose We performed an open-label randomized controlled phase III study comparing
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …
ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and …
M Gebre-Medhin, E Brun, P Engström… - Journal of Clinical …, 2021 - diva-portal.org
PURPOSE: We performed an open-label randomized controlled phase III study comparing
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …